Audiol Neurootol:在渗出性中耳炎儿童中使用移动应用评估听力阈值研究

2020-02-05 AlexYang MedSci原创

渗出性中耳炎(OME)是儿童中最常见的听力损失发病诱因。由于听力损失影响儿童言语和语言发展,因此早期的诊断时非常重要的。最近,有研究人员比较了传统的听力测定与安卓操作系统为基础的应用Hearing TestTM在评估OME儿童听力阈值方面的情况,并确定了移动应用测定的准确度和可靠性。研究包括了50名5岁到15岁且患有OME的学龄儿童,他们至少有1只耳朵患有OME。研究人员首先通过传统的听力测定方法

渗出性中耳炎(OME)是儿童中最常见的听力损失发病诱因。由于听力损失影响儿童言语和语言发展,因此早期的诊断时非常重要的。

最近,有研究人员比较了传统的听力测定与安卓操作系统为基础的应用Hearing TestTM在评估OME儿童听力阈值方面的情况,并确定了移动应用测定的准确度和可靠性。研究包括了50名5岁到15岁且患有OME的学龄儿童,他们至少有1只耳朵患有OME。研究人员首先通过传统的听力测定方法测定了听力阈值,并确定了听力损失的程度。之后,患者的听力阈值使用移动应用Hearing TestTM进行测量。研究人员使用了Cohen's kappa对数据进行了比较。研究发现,在88只耳朵中检测到了OME。在500、1000、2000和4000Hz,研究人员并没有发现移动应用和传统听力测定方法的听力阈值结果具有统计学显著相关性。

最后,研究人员指出,安卓手机应用Hearing TestTM(版本1.1.3)并不能够准确和可靠的检测OME儿童听力损失。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1951785, encodeId=217f1951e852d, content=<a href='/topic/show?id=dc43e51647a' target=_blank style='color:#2F92EE;'>#移动应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75164, encryptionId=dc43e51647a, topicName=移动应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 27 14:56:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306477, encodeId=d03413064e7b2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344511, encodeId=d8ca13445115d, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534938, encodeId=d3c91534938fd, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553620, encodeId=f4de1553620e8, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1951785, encodeId=217f1951e852d, content=<a href='/topic/show?id=dc43e51647a' target=_blank style='color:#2F92EE;'>#移动应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75164, encryptionId=dc43e51647a, topicName=移动应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 27 14:56:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306477, encodeId=d03413064e7b2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344511, encodeId=d8ca13445115d, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534938, encodeId=d3c91534938fd, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553620, encodeId=f4de1553620e8, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=)]
    2020-02-07 ysjykql
  3. [GetPortalCommentsPageByObjectIdResponse(id=1951785, encodeId=217f1951e852d, content=<a href='/topic/show?id=dc43e51647a' target=_blank style='color:#2F92EE;'>#移动应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75164, encryptionId=dc43e51647a, topicName=移动应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 27 14:56:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306477, encodeId=d03413064e7b2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344511, encodeId=d8ca13445115d, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534938, encodeId=d3c91534938fd, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553620, encodeId=f4de1553620e8, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1951785, encodeId=217f1951e852d, content=<a href='/topic/show?id=dc43e51647a' target=_blank style='color:#2F92EE;'>#移动应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75164, encryptionId=dc43e51647a, topicName=移动应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 27 14:56:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306477, encodeId=d03413064e7b2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344511, encodeId=d8ca13445115d, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534938, encodeId=d3c91534938fd, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553620, encodeId=f4de1553620e8, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1951785, encodeId=217f1951e852d, content=<a href='/topic/show?id=dc43e51647a' target=_blank style='color:#2F92EE;'>#移动应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75164, encryptionId=dc43e51647a, topicName=移动应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a8e213, createdName=hongbochen, createdTime=Fri Mar 27 14:56:00 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306477, encodeId=d03413064e7b2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1344511, encodeId=d8ca13445115d, content=<a href='/topic/show?id=a01b2239e0b' target=_blank style='color:#2F92EE;'>#中耳炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22397, encryptionId=a01b2239e0b, topicName=中耳炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1534938, encodeId=d3c91534938fd, content=<a href='/topic/show?id=cd9c392e372' target=_blank style='color:#2F92EE;'>#听力阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39273, encryptionId=cd9c392e372, topicName=听力阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c2112566955, createdName=aliceclz, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1553620, encodeId=f4de1553620e8, content=<a href='/topic/show?id=839e9e33475' target=_blank style='color:#2F92EE;'>#阈值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97334, encryptionId=839e9e33475, topicName=阈值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f4f14387940, createdName=qjddjq, createdTime=Fri Feb 07 03:56:00 CST 2020, time=2020-02-07, status=1, ipAttribution=)]
    2020-02-07 qjddjq

相关资讯

Eur Ann Allergy Clin Immunol:过敏性鼻炎在渗出性中耳炎儿童中的患病率分析

过敏性鼻炎在渗出性中耳炎儿童中的患病率在不同的国家中范围为82%到93%。之前的研究已经鉴定和证明了许多渗出性中耳炎的风险因子。然而,与过敏性鼻炎的相关性仍旧存在争议。最近,有研究人员确定了渗出性中耳炎儿童中过敏性鼻炎的患病率情况,并鉴定了渗出性中耳炎的相关风险因子,与过敏性鼻炎相关的常见过敏原,还确定了渗出性中耳炎儿童的听力阈值。研究共包括了130名儿童。研究发现,渗出性中耳炎儿童中过敏性鼻炎的

儿童急性中耳炎与合理用药

婴幼儿急性中耳炎是儿科的常见疾病,临床发病率仅此于感冒,也是感冒后极易引发的并发症。急性中耳炎宝宝常常表现为耳朵疼痛,啼哭不止,并经常用手抓耳朵,伴发热、拒绝吃奶等症状。如果伴有鼓膜穿孔,还可能见到脓性黏液分泌物流出耳外,患儿听力减退。

Clin Otolaryngol:渗出性中耳炎儿童中通风管对生活质量影响研究

最近,有研究人员确定了通风管(VT)手术对患有渗出性中耳炎(OME)儿童生活质量(QoL)的影响。研究人员都试验数据进行了二次分析,并利用多水平回归模型坚定了VT手术与QoL评分在第12个月时的相关性。研究是在威尔士和英格兰的耳鼻喉科和儿科听力学和听力学医学科部门进行的。研究总共包括了327名年龄在2-8岁的儿童,他们均患有至少3个月的OME症状,且具有听力测定确定的双边听力损失,且均进行了VT手

Eur Arch Otorhinolaryngol:软骨鼓室成形术损伤患者的听力么?

最近,有研究人员评估和比较了颞筋膜鼓室成形术的功能性治疗结果,在慢性中耳炎(COM)且具有正常术前听力水平的案例中比较了4种不同类型的软骨移植物的功能结果。研究总共包括了144名符合入选标准的患者。研究发现,术后TF组和CG组的PTA和气骨导差(ABG)水平显著减少(p=0.01)。相似的是,WRS得分在2个小组中也均显著的增加(p=0.001)。在PTA增加、WRS增加和ABG关闭水平方面,软骨

Sci Rep:过敏性鼻炎和中耳炎相关性分析

尽管许多研究报道了儿童中,过敏性鼻炎是一个独立的风险因子并与中耳炎高度相关,然而,仍旧缺乏关于人口统计学的流行病学研究。最近,有研究人员在韩国当地人口中,使用全国的调查数据鉴定了是否在年龄为7-12岁的儿童中,过敏性鼻炎是中耳炎的独立风险因子。研究包括了472名儿童(248名男性和224名女性),他们在2015年完成了韩国国家健康与营养调查。中耳炎由耳鼻喉科专家使用鼓室测量、听力测量和耳镜检查来鉴

Int J Pediatr Otorhinolaryngol:腺样体肥大对渗出性中耳炎儿童患者听力阈值的影响研究

渗出性中耳炎是一种常见的中耳粘膜疾病,能够引起儿童听力损失。腺样体肥大除了引起渗出性中耳炎之外,还能够引起复发性急性中耳炎。最近,有研究人员调查了腺样体肥大对渗出性中耳炎儿童患者听力阈值的影响。研究包括了50名年龄在5-15岁的儿童,共88只耳朵。在500?Hz、1000?Hz和2000?Hz时平均空气传导阈值均值在腺样体组织大小分组1-4组中分别为22?dB HL、20?dB HL、15?dB